Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Key points
  • Macquarie is bullish on a supermarket giant, citing successful market share expansion and strong sales growth, leading to an outperform rating and increased price target.
  • A biotech leader is seen as undervalued by Morgans, which maintains a buy rating despite a recent guidance downgrade, highlighting a buying opportunity due to low earnings multiples.
  • Macquarie's positive view on a buy now pay later provider is driven by its rapid growth and potential in the US market, resulting in a new coverage with a favorable price target.

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

Coles Group Ltd (ASX: COL)

According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating on this supermarket giant's shares with an improved price target of $26.10. The broker was pleased with Coles' first quarter update and notes that its sales growth outperformed its main rival. This suggests that its market share gains have continued. And with Coles appearing to be retaining its new shoppers, Macquarie believe it is well-placed to deliver strong earnings growth in the next three years. As a result, it thinks its shares are good value at current levels. The Coles share price ended the week at $22.05.

CSL Ltd (ASX: CSL)

A note out of Morgans reveals that its analysts have retained their buy rating on this biotech giant's shares with a reduced price target of $249.51. Although the broker concedes that CSL's guidance downgrade was disappointing and it remains unclear when US influenza vaccination rates will stabilise, it thinks the share price selldown has been severely overdone. As a result, Morgans believes that its shares are trading on unjustifiably low earnings multiples at present and is recommending investors buy the dip. The CSL share price was fetching $178.50 at Friday's close.

Zip Co Ltd (ASX: ZIP)

Another note out of Macquarie reveals that its analysts have initiated coverage on this buy now pay later provider's shares with a $4.85 price target. According to the note, the broker believes that Zip is an attractive investment option for Aussie investors thanks partly to its US segment. It highlights that this side of the business is currently outpacing peers. And despite US total transaction value (TTV) growing >40% annually, it still has a significant opportunity to acquire new customers in an underserved market. In light of this, it is forecasting Zip to continue to deliver rapid growth in the coming years. This will be supported by increased product adoption, expansion of merchant network, increased customer engagement, and digital product innovation. The Zip share price ended the week at $3.87.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A kid stretches up to reach the top of the ruler drawn on the wall behind.
Broker Notes

4 ASX 200 shares with 36% to 98% growth ahead: brokers

The experts see buying opportunities here.

Read more »

Senior man looking at his laptop and pondering something.
Broker Notes

Buy, hold, sell: Telix Pharmaceuticals, BHP, CBA shares

James Bills from Shaw and Partners shares his views and ratings on 3 ASX stocks.

Read more »

Numerous Australian dollar notes laid out.
Broker Notes

2 brokers' price targets on Zip shares might surprise you

The buy now, pay later company is looking like a bargain at current prices.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Analysts warn that these popular ASX shares are 'sells'

These shares have been given sell ratings by experts. But why?

Read more »

Man smiling ahead while working on his MacBook.
Broker Notes

Experts name 3 ASX 200 shares to buy

These shares have been given the thumbs up this week.

Read more »

Man analysing data on his laptop.
Broker Notes

Buy, hold, sell: Nick Scali, Medibank Private, BHP shares

Let's start the new week with some fresh ratings from the experts.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Broker Notes

6 ASX stocks receiving analyst downgrades this week

Brokers reduced their ratings on NextDC, Ampol, Regis Resources, and other stocks this week. 

Read more »